Lesions of the Female Genital System Caused by Diethylstilbestrol in Humans, Subhuman Primates, and Mice

  • Lorna D. Johnson
Part of the Monographs on Pathology of Laboratory Animals book series (LABORATORY)

Abstract

From 1945 to 1971 diethylstilbestrol (DES), a synthetic estrogen, was used extensively to prevent abortion in pregnant women. This use was discontinued when clear cell adenocarcinoma of the vagina in young women was associated with their exposure to DES in utero (Herbst et al. 1971). It is estimated that 500000 to 2000000 infants were exposed (Noller and Fish 1974). Examination of the exposed population has uncovered long-term effects in women, the oldest of whom are now beginning the 5th decade of life. These include a low incidence of the clear cell cancer (Herbst et al. 1977) and an increased incidence of cervical and vaginal intraepithelial squamous-cell neoplasia (Robboy et al. 1984).

Keywords

Adenocarcinoma Testosterone Sarcoma Luminal Progesterone 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Allen E, Gardner WU (1941) Cancer of the cervix of the uterus in hybrid mice following long-continued administration of estrogen. Cancer Res 1: 359–366Google Scholar
  2. Antonioli DA, Burke L, Friedman EA (1980) Natural history of diethylstilbestrol-associated genital tract lesions: cervical ectopy and cervicovaginal hood. Am J Obstet Gynecol 137: 847–853PubMedGoogle Scholar
  3. Bames AB, Colton T, Gundersen J, Noller KL, Tilley BC, Strama T, Townsend DE, Hatab P, O’Brien PC (1980) Fertility and outcome of pregnancy in women exposed in utero to diethylstilbestrol. N Engl J Med 302:609–613CrossRefGoogle Scholar
  4. Barter JF, Austin JM Jr, Shingleton HM (1986) Endometrial adenocarcinoma after in utero diethylstilbestrol exposure. Obstet Gynecol 67: 84S-85SPubMedGoogle Scholar
  5. Bern HA, Talamantes FJ Jr (1981) Neonatal mouse models and their relation to disease in the human female. In: Herbst AL, Bern HA (eds) Developmental effects of diethylstilbestrol (DES) in pregnancy. Thieme-Stratton, New York, pp 129–147Google Scholar
  6. Bern HA, Mills KT, Ostrander PL, Schoenrock B, Graveline B, Plapinger L (1984a) Cervicovaginal abnormalities in BALB/c mice treated neonatally with sex hormones. Teratology 30: 267–274PubMedCrossRefGoogle Scholar
  7. Bern HA, Mills KT, Mori T (1984b) Effects of long-term implantation of vaginal concretions on the cervicovaginal epithelium of mice. Proc Soc Exp Biol Med 177: 303–307PubMedGoogle Scholar
  8. DeChemey AH, Cholst I, Naftolin F (1981) Stmcture and function of the fallopian tubes following exposure to diethylstilbestrol (DES) during gestation. Fértil Steril 36: 741–745Google Scholar
  9. Dickersin GR, Welch WR, Eriandson R, Robboy SJ (1980) Ultrastmcture of 16 cases of clear cell adenocarcinoma of the vagina and cervix in young women. Cancer 45: 1615–1624PubMedCrossRefGoogle Scholar
  10. Drill VA (1979) Evaluation of the carcinogenic effects of estrogens, progestins, oral contraceptives on cervix, uterus and ovary of animals and man. Arch Toxicol Suppl 2:59–84CrossRefGoogle Scholar
  11. Dunn TB (1969) Cancer of the uterine cervix in mice fed a liquid diet containing an antifertility drug. JNCI 43: 671–692PubMedGoogle Scholar
  12. Dunn TB, Green AW (1963) Cysts of the epididymis, cancer of the cervix, granular cell myoblastoma, and other lesions after estrogen injection in newbom mice. JNCI 31:425–455PubMedGoogle Scholar
  13. Forsberg J-G (1969) The development of atypical epithelium in the mouse uterine cervix and vaginal fomix after neonatal oestradiol treatment. Br J Exp Pathol 50: 187–195PubMedGoogle Scholar
  14. Forsberg J-G (1972) Estrogen, vaginal cancer and vaginal development. Am J Obstet Gynecol 113: 83–87PubMedGoogle Scholar
  15. Forsberg J-G (1973) Cervicovaginal epithelium: its origin and development. Am J Obstet Gynecol 115:1025–1043PubMedGoogle Scholar
  16. Forsberg J-G (1975) Late effects in the vaginal and cervical epithelium after injections of diethylstilbestrol into neonatal mice. Am J Obstet Gynecol 121:101–104PubMedGoogle Scholar
  17. Forsberg J-G (1979) Developmental mechanism of estrogen-induced irreversible changes in the mouse cervicovaginal epithelium. In: Perinatal carcinogenesis. Natl Cancer Inst Monogr 51:41–56Google Scholar
  18. Forsberg J-G, Kalland T (1981) Neonatal estrogen treatment and epithelial abnormalities in the cervicovaginal epithelium of adult mice. Cancer Res 41: 721–734PubMedGoogle Scholar
  19. Goodman DG, Strandberg JD (1982) Neoplasms of the female reproductive system. In: Foster HL, Small JD, Fox JG (eds) The mouse in biomedical research. IV. Experimental biology and oncology. Academic, New York, pp 397–411Google Scholar
  20. Gorski RA, Harian RE, Christensen LW (1977) Perinatal hormonal exposure and the development of neuroendocrine regulatory processes. J Toxicol Environ Health 3:97–121PubMedCrossRefGoogle Scholar
  21. Haney AF, Newbold RR, McLachlan JA (1984) Prenatal diethylstilbestrol exposure in the mouse: effects on ovarian histology and steroidogenesis in vitro. Biol Reprod 30:471–478PubMedCrossRefGoogle Scholar
  22. Haney AF, Newbold RR, Fetter BF, McLachlan JA (1986) Paraovarian cysts associated with prenatal diethylstilbestrol exposure. Comparison of the human with a mouse model. Am J Pathol 124: 405–411PubMedGoogle Scholar
  23. Hendrickx AG, Benirschke K, Thompson RS, Ahem JK, Lucas WE, Oi RH (1979) The effects of prenatal diethylstilbestrol (DES) exposure on the genitalia of pubertal Macaca mulatta. I. Female offspring. J Reprod Med 22: 233–240PubMedGoogle Scholar
  24. Herbst AL, Ulfelder H, Poskanzer DC (1971) Adenocarcinoma of the vagina. Association of matemal stilbestrol therapy with tumor appearance in young women. N Engl J Med 284:878–881PubMedCrossRefGoogle Scholar
  25. Herbst AL, Kurman RG, Scully RE (1972) Vaginal and cervical abnormalities after exposure to stilbestrol in utero. Obstet Gynecol 40: 287–298PubMedGoogle Scholar
  26. Herbst AL, Cole P, Colton T, Robboy SJ, Scully RE (1977) Age-incidence and risk of diethylstilbestrol related clear cell adenocarcinoma of the vagina and cervix. Am J Obstet Gynecol 128: 43–50PubMedGoogle Scholar
  27. Herbst AL, Nomsis MJ, Rosenow PJ, Welch WR, Scully RE (1979) An analysis of 346 cases of clear cell adenocarcinoma of the vagina and cervix with emphasis on recurrence and survival. Gynecol Oncol 7:111–122PubMedCrossRefGoogle Scholar
  28. Herbst AL, Hubby MM, Blough RR, Azizi F (1980) A comparison of pregnancy experience in DES-exposed and DES-unexposed daughters. J Reprod Med 24: 62–69PubMedGoogle Scholar
  29. Hertig AT, Gore H (1961) Tumors of the ovary and fallopian tube. In: Atlas of tumor pathology, section 9, fascicle 33. Tumors of the female sex organs, part 3. AFIP, Washington, DC, pp 9–176Google Scholar
  30. Heston WE, Vlahakis G, Desmukes B (1973) Effects of the antifertility dmg enovid in five strains of mice, with particular regard to carcinogenesis. JNCI 51: 209–224PubMedGoogle Scholar
  31. Highman B, Norvell MJ, Shellenberger TE (1977) Pathological changes in female C3H mice continuously fed diets containing diethylstilbestrol or 17B-estradiol. J Environ Pathol Toxicol 1:1–30Google Scholar
  32. Huseby RA, Thuriow S (1982) Effects of prenatal exposure of mice to, low-dose’ diethylstilbestrol and the development of adenomyosis associated with evidence of hyperprolactinemia. Am J Obstet Gynecol 144: 939–949PubMedGoogle Scholar
  33. Iguchi T, Ostrander PL, Mills KT, Bern HA (1985) Induction of abnormal epithelial changes by estrogen in neonatal mouse vaginal transplants. Cancer Res 45: 5688–5693PubMedGoogle Scholar
  34. Iguchi T, Takase M, Takasugi N (1986) Development of vaginal adenosis-like lesions and uterine epithelial stratification in mice exposed prenatally to diethylstilbestrol (42224). Proc Soc Exp Biol Med 181: 59–65PubMedGoogle Scholar
  35. Johnson LD (1969) The histopathological approach to early cervical neoplasia. Obstet Gynecol Surv 24:735–767PubMedCrossRefGoogle Scholar
  36. Johnson LD (1984) The effects of prenatal diethylstilbestrol exposure on the genital tracts of fetuses and neonates (Cebus apella, Macaca mulatta, and Homo sapiens). In: Ryder OA, Byrd ML (eds) One medicine. Springer, Berlin Heidelberg New York, pp 197–216CrossRefGoogle Scholar
  37. Johnson LD, Driscoll SG, Hertig AT, Cole PT, Nickerson RJ (1979) Vaginal adenosis in stillboms and neonates exposed to diethylstilbestrol and steroidal estrogens and progestins. Obstet Gynecol 53: 671–679PubMedGoogle Scholar
  38. Johnson LD, Palmer AE, King NW Jr, Hertig AT (1981) Vaginal adenosis in Cebus apella monkeys exposed to DES in utero. Obstet Gynecol 57: 629–635PubMedGoogle Scholar
  39. Jones LA, Pacillas-Verjan R (1979) Transplantability and sex steroid hormone responsiveness of cervicovaginal tumors derived from female BALB/c Crgl mice neonatally treated with ovarian steroids. Cancer Res 39: 2591–2594PubMedGoogle Scholar
  40. Kaufman RH, Adam E, Binder GL, Gerthoffer EA (1980) Upper genital tract changes and pregnancy outcome in offspring exposed in utero to diethylstilbestrol. Am J Obstet Gynecol 137: 299–308PubMedGoogle Scholar
  41. Kaufman RH, Noller K, Adam E, Irwin J, Gray M, Jeffries JA, Hilton J (1984) Upper genital tract abnormalities and pregnancy outcome in diethylstilbestrol-exposed progeny. Am J Obstet Gynecol 148: 973–984PubMedGoogle Scholar
  42. Kimura T (1975) Persistent vaginal comification in mice treated with estrogen prenatally. Endocrinol Jpn 22: 497–502PubMedCrossRefGoogle Scholar
  43. Kimura T, Nandi S (1967) Nature of induced peristent vaginal comification in mice. IV. Changes in the vaginal epithelium of old mice treated neonatally with estradiol and testosterone. JNCI 39: 75–93PubMedGoogle Scholar
  44. Lemon PG, Gubareva AV (1979) Tumours of the ovary. In: Turusov VS (ed) Pathology of tumours in laboratory animals. II. Tumours of the mouse. IARC Sci Publ 23: 385–397Google Scholar
  45. Maier DB, Newbold RR, McLachlan JA (1985) Prenatal diethylstilbestrol exposure alters murine uterine responses to prepubertal estrogen stimulation. Endocrinology 116:1878–1886PubMedCrossRefGoogle Scholar
  46. McLachlan JA, Newbold RR, Bullock BC (1980) Long-term effects on the female mouse genital tract associated with prenatal exposure to diethylstilbestrol. Cancer Res 40:3988–3999PubMedGoogle Scholar
  47. McLachlan JA, Newbold RR, Shah HC, Hogan MD, Dixon RL (1982) Reduced fertility in female mice exposed transplacentally to diethylstilbestrol (DES). Fertil Steril 38:364–371PubMedGoogle Scholar
  48. Mori T, Iguchi T, Takasugi N (1983) Origin of permanently altered epithelial cells of the vagina in neonatally estrogen-treated mice. J Exp Zool 225:99–105PubMedCrossRefGoogle Scholar
  49. Mori T (1979) Age-related changes in ovarian responsiveness to gonadotropins in normal and neonatally estrogenized mice. J Exp Zool 207: 451–458PubMedCrossRefGoogle Scholar
  50. Muñoz N, Dunn TB, Tumsov VS (1979) Tumours of the vagina and uterus. In: Tumsov VS (ed) Pathology of tumours in laboratory animals. II. Tumours of the mouse. IARC Sci Publ 23:359–383Google Scholar
  51. Newbold RR, McLachlan JA (1982) Vaginal adenosis and adenocarcinoma in mice exposed prenatally or neonatally to diethylstilbestrol. Cancer Res 42: 2003–2011PubMedGoogle Scholar
  52. Newbold RR, McLachlan JA (1985) Diethylstilbestrol associated defects in murine genital tract development. In: McLachlan JR (ed) Estrogens in the environment. II. Influences on development. Elsevier, New York, pp 288–318Google Scholar
  53. Newbold RR, Bullock BC, McLachlan JA (1983a) Exposure to diethylstilbestrol during pregnancy permanently alters the ovary and oviduct. Biol Reprod 28:735–744PubMedCrossRefGoogle Scholar
  54. Newbold RR, Tyrey S, Haney AF, McLachlan JA (1983b) Developmentally arrested oviduct: a stmctural and functional defect in mice following prenatal exposure to diethylstilbestrol. Teratology 27:417–426PubMedCrossRefGoogle Scholar
  55. Newbold RR, Bullock BC, McLachlan JA (1984) Diverticulosis and salpingitis isthmica nodosa (SIN) of the fallopian tube. Estrogen-induced diverticulosis and SIN of the mouse oviduct. Am J Pathol 117: 333–335PubMedGoogle Scholar
  56. Noller KL, Fish CR (1974) Diethylstilbestrol usage: its interesting past, important present, and questionable future. Med Clin North Am 58: 793–810PubMedGoogle Scholar
  57. Noller KL, Townsend DE, Kaufman RH, Bames AB, Robboy SJ, Fish CR, Jefferies JA, Bergstrahl EJ, O’Brien PC, McGorray SP, Scully R (1983) Maturation of vaginal and cervical epithelium in women exposed in utero to diethylstilbestrol (DESAD Project). Am J Obstet Gynecol 146: 279–285PubMedGoogle Scholar
  58. Nomura T, Kanzaki T (1977) Induction of urogenital anomalies and some tumors in the progeny of mice receiving diethylstilbestrol during pregnancy. Cancer Res 37:1099–1104PubMedGoogle Scholar
  59. Nomura T, Masuda M (1980) Carcinogenic and teratogenic activities of diethylstilbestrol in mice. Life Sci 26: 1955–1962PubMedCrossRefGoogle Scholar
  60. Ostrander PL, Mills KT, Bern HA (1985) Long-term responses of the mouse uterus to neonatal diethylstilbestrol treatment and to later sex hormone exposure. JNCI 74:121–135PubMedGoogle Scholar
  61. Plapinger L, Bern HA (1979) Adenosis-like lesions and other cervicovaginal abnormalities in mice treated perinatally with estrogen. JNCI 63: 507–518PubMedGoogle Scholar
  62. Robboy SJ, Welch WR (1977) Microglandular hyperplasia in vaginal adenosis associated with oral contraceptives and prenatal diethylstilbestrol exposure. Obstet Gynecol 49: 430–434PubMedGoogle Scholar
  63. Robboy SJ, Young RH, Herbst AL (1982a) Female genital tract changes related to prenatal diethylstilbestrol exposure. In: Blaustein A (ed) Pathology of female genital tract, 2nd edn. Springer, Berlin Heidelberg New York, pp 99–118Google Scholar
  64. Robboy SJ, Taguchi O, Cunha GR (1982b) Normal development of the human female reproductive tract and alterations resulting from experimental exposure to diethylstilbestrol. Hum Pathol 13:190–198PubMedCrossRefGoogle Scholar
  65. Robboy SJ, Noller KL, O’Brien P, Kaufman RH, Townsend D, Bames AB, Gundersen J, Lawrence WD, Bergstrahl E, McGorray S, Tilley BC, Anton J, Chazen G (1984) Increased incidence of cervical and vaginal dysplasia in 3, 980 diethylstilbestrol-exposed young women. JAMA 252: 2979–2983PubMedCrossRefGoogle Scholar
  66. Ryder OA, Byrd ML (1984) One medicine. Springer, Berlin Heidelberg New YorkCrossRefGoogle Scholar
  67. Scully RE, Welch WR (1981) Pathology of the female genital tract after prenatal exposure to diethylstilbestrol. In: Herbst AL, Bern HA (eds) Developmental effects of diethylstilbestrol (DES) in pregnancy. Thieme-Stratton, New York, pp 26–45Google Scholar
  68. Stafl A, Mattingly RF, Foley DV, Fetherston WC (1974) Clinical diagnosis of vaginal adenosis. Obstet Gynecol 43:118–127PubMedGoogle Scholar
  69. Suntzeff V, Bums EL, Moskop M, Loeb L (1938) On the proliferative changes taking place in the epithelium of vagina and cervix of mice with advancing age and under the influence of experimentally administered estrogenic hormones. Am J Cancer 32: 256–289PubMedGoogle Scholar
  70. Takasugi N (1972) Carcinogenesis by vaginal transplants from ovariectomized neonatally estrogenized mice into ovariectomized normal hosts. Gann 63: 73–77PubMedGoogle Scholar
  71. Takasugi N (1971) Morphogenesis of estrogen-independent proliferation and comification of the vaginal epithelium in neonatally estrogenized mice. Proc Jpn Acad 47:193–198Google Scholar
  72. Takasugi N (1979) Development of permanently proliferated and comified vaginal epithelium in mice treated neonatally with steroid hormones and the implication in tumorigenesis. In: Perinatal carcinogenesis. Nat Cancer Inst Monogr 51: 57–66Google Scholar
  73. Takasugi N, Bern HA (1962) Crystals and concretions in the vaginae of persistent-estrous mice. Proc Soc Exp Biol Med 109: 622–624PubMedGoogle Scholar
  74. Takasugi N, Bern HA (1964) Tissue changes in mice with persistent vaginal comification induced by early postnatal treatment with estrogen. JNCI 33: 855–865PubMedGoogle Scholar
  75. Takasugi N, Tomooka Y (1976) Alteration of the critical period for induction of persistent oestms by early postnatal treatment with gonadal steroids in neonatally cortisone-primed mice. J Endocrinol 69: 293–294PubMedCrossRefGoogle Scholar
  76. Takasugi N, Kimura T, Mori T (1970) Irreversible changes in mouse vaginal epithelium induced by early postnatal treatment with steroid hormones. In: Kazda S, Denenberg VH (eds) The postnatal development of phenotype. Butterworth, London, pp 229–251Google Scholar
  77. Tenenbaum A, Forsberg J-G (1985) Stmctural and functional changes in ovaries from adult mice treated with diethylstilbestrol in the neonatal period. J Reprod Fert 73:465–477CrossRefGoogle Scholar
  78. Walker BE (1980) Reproductive tract anomalies in mice after prenatal exposure to DES. Teratology 21:313–321PubMedCrossRefGoogle Scholar
  79. Walker BE (1983) Uterine tumors in old female mice exposed prenatally to diethylstilbestrol. JNCI 70:477–484PubMedGoogle Scholar
  80. Walker BE (1984) Tumors of female offspring of mice exposed prenatally to diethylstilbestrol. JNCI 73:133–140PubMedGoogle Scholar
  81. Whelton J, Kottmeier HL (1962) Primary carcinoma of the vagina: a study of the Radiumhemmet series of 145 cases. Acta Obstet Gynecol Scand 41: 22–40PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1987

Authors and Affiliations

  • Lorna D. Johnson

There are no affiliations available

Personalised recommendations